Close
Found 0 results for your search. Showing 0 to 0.
No results could be found for your search.
x Close Search
Close

Publications

The landscape of diagnostic mycobacteriology in Germany-challenges of decentralised care.
Maurer, FP; Mintken, E; Rupp, J; OLARU, I; KRANZER, K;
2019
The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease, (2019).23 8 10.5588/ijtld.18.0763.
TB Fast Track: a study to evaluate the effect of a point-of-care TB test-and-treat algorithm on early mortality in people with HIV accessing ART, a trial with randomisation at clinic level.
FIELDING, K; Charalambous, S; Hoffmann, CJ; Johnson, S; Tlali, M; Dorman, SE; VASSALL, A; Churchyard, GJ; GRANT, AD;
2019
, London School of Hygiene & Tropical Medicine (2019). 10.17037/PUBS.04653158.
Potential population level impact on tuberculosis incidence of using an mRNA expression signature correlate-of-risk test to target tuberculosis preventive therapy.
SUMNER, T; Scriba, TJ; Penn-Nicholson, A; Hatherill, M; WHITE, RG;
2019
Scientific Reports, (2019).9 1 10.1038/s41598-019-47645-z.
Implementation science to improve the quality of tuberculosis diagnostic services in Uganda.
Cattamanchi, A; Berger, CA; Shete, PB; Turyahabwe, S; Joloba, M; MOORE, DA; Davis, LJ; Katamba, A;
2019
Journal of clinical tuberculosis and other mycobacterial diseases, (2019).18, 10.1016/j.jctube.2019.100136.
Space-time clustering of recently-diagnosed tuberculosis and impact of ART scale-up: Evidence from an HIV hyper-endemic rural South African population.
Tomita, A; Smith, CM; Lessells, RJ; Pym, A; GRANT, AD; De Oliveira, T; Tanser, F;
2019
Scientific Reports, (2019).9 1 10.1038/s41598-019-46455-7.
Rhombencephalitis and Myeloradiculitis Caused by a European Subtype of Tick-Borne Encephalitis Virus.
Neill, L; Checkley, AM; Benjamin, LA; Herdman, MT; Carter, DP; Pullan, ST; Aarons, E; Griffiths, K; Monaghan, B; Karunaratne, K; Ciccarelli, O; Spillane, J; MOORE, DA J; Kullmann, DM;
2019
Emerging infectious diseases, (2019).25 12 10.3201/eid2512.191017.
Global burden of latent multidrug-resistant tuberculosis: trends and estimates based on mathematical modelling.
KNIGHT, GM; MCQUAID, CF; Dodd, PJ; HOUBEN, RM G J;
2019
Lancet Infectious Diseases, (2019).19 8 10.1016/S1473-3099(19)30307-X.
Vulnerable populations and the right to health: lessons from the Peruvian Amazon around tuberculosis control.
Gianella, C; Pesantes, MA; Ugarte-Gil, C; MOORE, DA J; Lema, C;
2019
INTERNATIONAL JOURNAL FOR EQUITY IN HEALTH, (2019).18 1 10.1186/s12939-019-0928-z.
Correction: Discovery and validation of a prognostic proteomic signature for tuberculosis progression: A prospective cohort study.
Penn-Nicholson, A; Hraha, T; Thompson, EG; Sterling, D; Mbandi, SK; Wall, KM; Fisher, M; Suliman, S; Shankar, S; Hanekom, WA; Janjic, N; Hatherill, M; Kaufmann, SH E; SUTHERLAND, J; Walzl, G; De Groote, MA; Ochsner, U; Zak, DE; Scriba, TJ; ACS and GC6–74 cohort study groups,;
2019
PLoS medicine, (2019).16 7 10.1371/journal.pmed.1002880.
Quality of care for patients evaluated for tuberculosis in the context of Xpert MTB/RIF scale-up.
Farr, K; Nalugwa, T; Ojok, C; Nantale, M; Nabwire, S; Oyuku, D; Shete, PB; Han, AH; FIELDING, K; Joloba, M; Mugabe, F; Dowdy, DW; MOORE, D; Davis, JL; Katamba, A; Cattamanchi, A;
2019
Journal of Clinical Tuberculosis and Other Mycobacterial Diseases, (2019).15, 10.1016/j.jctube.2019.100099.